IGF-I activates caspases 3/7, 8 and 9 but does not induce cell death in colorectal cancer cells
<p>Abstract</p> <p>Background</p> <p>Colorectal cancer is the third most common cancer in the western world. Chemotherapy is often ineffective to treat the advanced colorectal cancers due to the chemo-resistance. A major contributor to chemo-resistance is tumour-derived...
Main Authors: | Seifalian Alexander M, Fuller Barry, Sales Kevin M, Bolvin Capucine, Yang Shi Yu, Winslet Marc C |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-05-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/9/158 |
Similar Items
-
Inducing apoptosis of human colon cancer cells by an IGF-I D domain analogue peptide
by: Seifalian Alexander M, et al.
Published: (2008-02-01) -
Does Doxycycline work in synergy with cisplatin and oxaliplatin in colorectal cancer?
by: Taanman JanWillem, et al.
Published: (2009-01-01) -
Cyclooxygenase/lipoxygenase shunting lowers the anti-cancer effect of cyclooxygenase-2 inhibition in colorectal cancer cells
by: Ganesh Radhakrishnan, et al.
Published: (2012-09-01) -
Role of stem cells in cancer therapy and cancer stem cells: a review
by: Sales Kevin, et al.
Published: (2007-06-01) -
Caspase-independent cell death does not elicit a proliferative response in melanoma cancer cells
by: Ahlima Roumane, et al.
Published: (2018-07-01)